Abstract
Background
We often encounter preterm infants with Down syndrome (DS) who die in the neonatal intensive care unit (NICU). In this study, we examined survival until NICU discharge and assessed the developmental prognosis of preterm infants with DS.
Methods
We retrospectively reviewed 416 infants with DS hospitalized during the past 27 years at our NICU.
Results
Death occurred in 8/20 (40%) infants at <32 weeks’ gestation, 11/23 (48%) at 32–33 weeks, 9/99 (9%) at 34–36 weeks, and 9/274 (3%) at >36 weeks. In total, 84% of infants who died and 25% of those who survived had a non-reassuring fetal status (p < 0.001). Sex, small-for-gestational-age status, and postnatal transport were not associated with death. The main causes of death were bronchopulmonary dysplasia in 4/8 (50%) infants at <32 weeks’ gestation, transient abnormal myelopoiesis in 11/20 (55%) and lymphatic dysplasia in 6/20 (30%) at 32–36 weeks, and varied causes at >36 weeks. Among survivors born at <34 weeks’ gestation, 6/19 (32%) aged >2 years had moderate or severe cerebral palsy.
Conclusions
These data on the high mortality and morbidity of preterm infants with DS may be useful for patient treatment and parent counseling in NICUs treating critically ill infants.
Impact
-
Most infants with Down syndrome born at <34 weeks’ gestation are born by cesarean section because of the non-reassuring fetal status.
-
The mortality rate before discharge for infants with Down syndrome born at <34 weeks’ gestation was 40%, and 30% of survivors developed moderate or severe cerebral palsy.
-
The risk of death due to bronchopulmonary dysplasia and pulmonary hypertension was high in very preterm infants with Down syndrome despite the absence of chorioamnionitis.
-
Infants with Down syndrome were born 1–2 weeks earlier than unaffected controls.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 14 print issues and online access
$259.00 per year
only $18.50 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Englund, A., Jonsson, B., Zander, C. S., Gustafsson, J. & Anneren, G. Changes in mortality and causes of death in the Swedish Down syndrome population. Am. J. Med. Genet A 161A, 642–649 (2013).
Yang, Q., Rasmussen, S. A. & Friedman, J. M. Mortality associated with Down’s syndrome in the USA from 1983 to 1997: a population-based study. Lancet 359, 1019–1025 (2002).
Weijerman, M. E. et al. Prevalence, neonatal characteristics, and first-year mortality of Down syndrome: a national study. J. Pediatr. 152, 15–19 (2008).
Chua, G. T. et al. Mortality among children with Down syndrome in Hong Kong: a population-based cohort study from birth. J. Pediatr. 218, 138–145 (2020).
Platt, M. J. Outcomes in preterm infants. Public Health 128, 399–403 (2014).
Isayama, T. The clinical management and outcomes of extremely preterm infants in Japan: past, present, and future. Transl. Pediatr. 8, 199–211 (2019).
Glasson, E. J., Jacques, A., Wong, K., Bourke, J. & Leonard, H. Improved survival in Down syndrome over the last 60 years and the impact of perinatal factors in recent decades. J. Pediatr. 169, 214–220.e211 (2016).
Kucik, J. E., Shin, M., Siffel, C., Marengo, L. & Correa, A. Trends in survival among children with Down syndrome in 10 regions of the United States. Pediatrics 131, e27–e36 (2013).
Goldman, S. E., Urbano, R. C. & Hodapp, R. M. Determining the amount, timing and causes of mortality among infants with Down syndrome. J. Intellect. Disabil. Res. 55, 85–94 (2011).
Rasmussen, S. A., Wong, L. Y., Correa, A., Gambrell, D. & Friedman, J. M. Survival in infants with Down syndrome, Metropolitan Atlanta, 1979-1998. J. Pediatr. 148, 806–812 (2006).
Ishida, S. et al. Evaluation of newborns with Down syndrome with weight less than 1500 g in the neonatal intensive care unit: a Japanese multicentre study. J. Paediatr. Child Health 59, 912–918 (2023).
Büttiker, V., Fanconi, S. & Burger, R. Chylothorax in children: guidelines for diagnosis and management. Chest 116, 682–687 (1999).
Palisano, R. et al. Development and reliability of a system to classify gross motor function in children with cerebral palsy. Dev. Med. Child. Neurol. 39, 214–223 (1997).
Boghossian, N. S. et al. Survival and morbidity outcomes for very low birth weight infants with Down syndrome. Pediatrics 126, 1132–1140 (2010).
Higgins, R. D. et al. Bronchopulmonary dysplasia: executive summary of a workshop. J. Pediatr. 197, 300–308 (2018).
Stoll, B. J. et al. Trends in care practices, morbidity, and mortality of extremely preterm neonates, 1993-2012. JAMA 314, 1039–1051 (2015).
Bruijn, M., van der Aa, L. B., van Rijn, R. R., Bos, A. P. & van Woensel, J. B. High incidence of acute lung injury in children with Down syndrome. Intensive Care Med. 33, 2179–2182 (2007).
Klusmann, J. H. et al. Treatment and prognostic impact of transient leukemia in neonates with Down syndrome. Blood 111, 2991–2998 (2008).
Witlox, R. et al. Neonatal management and outcome after thoracoamniotic shunt placement for fetal hydrothorax. Arch. Dis. Child. Fetal Neonatal Ed. 103, F245–f249 (2018).
Kelly, E. N. et al. Short- and long-term outcome following thoracoamniotic shunting for fetal hydrothorax. Ultrasound Obstet. Gynecol. 57, 624–630 (2021).
Oskoui, M., Coutinho, F., Dykeman, J., Jetté, N. & Pringsheim, T. An update on the prevalence of cerebral palsy: a systematic review and meta-analysis. Dev. Med. Child. Neurol. 55, 509–519 (2013).
Kurosawa, K. et al. Spastic quadriplegia in Down syndrome with congenital duodenal stenosis/atresia. Congenit. Anom. 52, 78–81 (2012).
Uehara, R., Miura, F., Itabashi, K., Fujimura, M. & Nakamura, Y. Distribution of birth weight for gestational age in Japanese infants delivered by cesarean section. J. Epidemiol. 21, 217–222 (2011).
Itabashi, K. et al. The introduction of a new birthweight standard by gestational age. J. Jpn. Pediatr. Soc. 114, 1271–1293 (2010).
Morris, J. K., Cole, T. J., Springett, A. L. & Dennis, J. Down syndrome birth weight in England and Wales: implications for clinical practice. Am. J. Med. Genet A 167A, 3070–3075 (2015).
Motegi, N., Yamaoka, Y., Moriichi, A. & Morisaki, N. Causes of death in patients with Down syndrome in 2014–2016: a population study in Japan. Am. J. Med. Genet. Part A 188, 224–236 (2022).
Sasaki, A. & Sago, H. Equipoise of recent estimated down syndrome live births in Japan. Am. J. Med. Genet. Part A 179, 1815–1819 (2019).
Flasinski, M. et al. Low-dose cytarabine to prevent myeloid leukemia in children with Down syndrome: TMD Prevention 2007 Study. Blood Adv. 2, 1532–1540 (2018).
Acknowledgements
We thank Angela Morben, DVM, ELS, from Edanz (https://jp.edanz.com/ac), for editing a draft of this manuscript.
Author information
Authors and Affiliations
Contributions
T. Shimokaze: conceptualization and design, original draft preparation. K. Toyoshima: conceptualization and supervision. T. Saito and K. Katsumata: data curation, investigation. T. Kemmotsu and H. Ishikawa: reviewing. K. Kurosawa: review of patients being followed up on an outpatient basis. All authors gave final approval for the version to be published.
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing interests.
Ethics approval and consent to participate
The parents or guardians of infants admitted to the NICU were not required to give informed consent for the infants’ participation in the study because the analysis used anonymized clinical data that were obtained after the guardians of each patient agreed to treatment by providing their written consent. We also adopted an opt-out system and posted a summary of the study on the hospital’s website (https://kcmc.kanagawa-pho.jp/about/ethics/conduct_research).
Additional information
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Shimokaze, T., Toyoshima, K., Saito, T. et al. Death of children with Down syndrome by gestational age and cause. Pediatr Res 95, 1325–1330 (2024). https://doi.org/10.1038/s41390-023-02870-1
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41390-023-02870-1
This article is cited by
-
High mortality rate of preterm infants with Down syndrome
Pediatric Research (2024)